
All News
All series
All All News



Lung cancer treatment continues to make strides.




Learn tips on figuring out what causes cancer-related fatigue and how to manage it.

Patients with myelofibrosis have few options for relief from an enlarged spleen, a side effect of the cancer, but there is hope on the horizon.

Regional lymph node radiation could benefit certain patients.


New research has shown that high-dose methotrexate improved five-year event-free survival for ALL patients with no significant differences in toxicities.


Melanoma studies with Yervoy and vemurafenib show benefit in advanced disease.

Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention.

Latest study results on PARP inhibitor iniparib disappointing, but may be helpful in second-line therapy.

Biomarker research might reveal neuropathy risk with certain cancer therapies.

HPV-positive oral cancers are on the rise.

Avastin appears to reduce relative risk of disease progression in recurring ovarian cancer.

New cancer cell-trapping method could result in improved treatment.



















